Our in-depth knowledge of global regulatory submission requirements allows us to guide clients through the complexities of clinical trial approvals and regulatory pathways.
The Micron Group provides comprehensive regulatory affairs support for the preparation of applications including Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Biologics License Applications (BLAs).
Expert guidance through every regulatory milestone — from early-phase planning to final submission.
We provide clinical and regulatory medical writing services throughout the product development lifecycle, from preclinical through Phase I to Phase IV clinical trials.
Our regulatory writing capabilities include:
109B Lancaster Way Business Park
CB6 3NX, Ely, Cambridgeshire
England, United Kingdom
12022 Blue Valley Parkway, Overland Park
Kansas 66213, United States of America
Route 21 Corporate Park, 5 Regency Drive, Building C
Irene 0157, Centurion, South Africa
Harju maakond, Tallinn, Kesklinna linnaosa
Viru väljak 2, Tallinn 10111, Estonia
Route 21 Corporate Park, 9 Regency Drive, Building B
Irene 0157, Centurion, South Africa